Form D · Biotechnology
Molecular Stethoscope, Inc.
San Diego, CA · CIK 0001790221
Offering snapshot reported Oct 7, 2019 · SEC filing
- Reported sold
- $4.49M Offering amount: $5.6M
- Investors reported
- 15 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 20, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 7, 2019 | Initial | $4,491,643 | No comparison | 15 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-350487
Total Offering Amount and Total Amount Sold includes amounts paid pursuant to conversion of indebtedness.
Source: Form D, filed Oct 7, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Guillermo M. Elias, Ph.D. | Executive |
| Arda Minocherhomjee, Ph.D. | Director |
| Tina S. Nova, Ph.D. | Director |
| Stephen Quake, D. Phil. | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
3210 Merryfield Row
San Diego, CA, 92121
San Diego, CA, 92121